323 related articles for article (PubMed ID: 29017824)
21. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
McConnell YJ; Mack LA; Francis WP; Ho T; Temple WJ
J Surg Oncol; 2013 May; 107(6):591-6. PubMed ID: 23129533
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer.
Chen JC; Beal EW; Hays J; Pawlik TM; Abdel-Misih S; Cloyd JM
J Surg Oncol; 2020 Sep; 122(3):388-398. PubMed ID: 32383206
[TBL] [Abstract][Full Text] [Related]
23. The impact of HIPEC
Leiting JL; Day CN; Harmsen WS; Cloyd JM; Abdel-Misih S; Fournier K; Lee AJ; Dineen S; Dessureault S; Veerapongh J; Baumgartner JM; Clarke C; Mogal H; Russell MC; Zaidi MY; Patel SH; Morris MC; Hendrix RJ; Lambert LA; Abbott DE; Pokrzywa C; Raoof M; Eng O; Johnston FM; Greer J; Grotz TE
Int J Hyperthermia; 2020; 37(1):1182-1188. PubMed ID: 33040617
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2016 Feb; 23(2):382-90. PubMed ID: 26429720
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: A propensity score analysis.
Soucisse ML; Fisher O; Liauw W; Ghanipour L; Cashin P
Eur J Surg Oncol; 2021 Jan; 47(1):157-163. PubMed ID: 32943277
[TBL] [Abstract][Full Text] [Related]
26. PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries.
Votanopoulos KI; Bartlett D; Moran B; Haroon CM; Russell G; Pingpank JF; Ramalingam L; Kandiah C; Chouliaras K; Shen P; Levine EA
Ann Surg Oncol; 2018 Mar; 25(3):674-678. PubMed ID: 29288288
[TBL] [Abstract][Full Text] [Related]
27. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L
World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618
[TBL] [Abstract][Full Text] [Related]
28. The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Milovanov V; Sardi A; Studeman K; Nieroda C; Sittig M; Gushchin V
Ann Surg Oncol; 2016 Jun; 23(6):1928-33. PubMed ID: 26714951
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
[TBL] [Abstract][Full Text] [Related]
30. A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ihemelandu C; Fernandez S; Sugarbaker PH
Ann Surg Oncol; 2017 Aug; 24(8):2266-2272. PubMed ID: 28342015
[TBL] [Abstract][Full Text] [Related]
31. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
32. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.
Reghunathan M; Kelly KJ; Valasek MA; Lowy AM; Baumgartner JM
Ann Surg Oncol; 2018 Mar; 25(3):702-708. PubMed ID: 29282599
[TBL] [Abstract][Full Text] [Related]
33. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
34. Use of early postoperative intraperitoneal 5-fluorouracil with index cytoreduction improves survival with secondary cytoreductive surgery.
Sugarbaker PH; Chang D
J Surg Oncol; 2024 Feb; 129(2):349-357. PubMed ID: 37822274
[TBL] [Abstract][Full Text] [Related]
35. Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study.
Madsen AH; Ladekarl M; Villadsen GE; Grønbæk H; Sørensen MM; Stribolt K; Verwaal VJ; Iversen LH
Ann Surg Oncol; 2018 Feb; 25(2):422-430. PubMed ID: 29214450
[TBL] [Abstract][Full Text] [Related]
36. Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm.
Mercado M; Shamavonian R; Cheng E; Ahmadi N; Morris DL
Anticancer Res; 2023 Feb; 43(2):817-822. PubMed ID: 36697077
[TBL] [Abstract][Full Text] [Related]
37. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
Sugarbaker PH; Chang D
Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
[TBL] [Abstract][Full Text] [Related]
38. Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Lyon TD; Turner Ii RM; Nikonow TN; Wang L; Uy J; Ramalingam L; Holtzman MP; Pingpank JF; Bartlett DL; Davies BJ
J Surg Oncol; 2016 Feb; 113(2):218-22. PubMed ID: 26775909
[TBL] [Abstract][Full Text] [Related]
39. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.
Downs-Canner S; Ding Y; Magge DR; Jones H; Ramalingam L; Zureikat A; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2015 May; 22(5):1651-7. PubMed ID: 25348781
[TBL] [Abstract][Full Text] [Related]
40. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
Teo MC; Tan GH; Tham CK; Lim C; Soo KC
Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]